Detalles de la búsqueda
1.
Exercise in newly diagnosed patients with multiple myeloma: A randomized controlled trial of effects on physical function, physical activity, lean body mass, bone mineral density, pain, and quality of life.
Eur J Haematol
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717071
2.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35123422
3.
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Eur J Haematol
; 108(1): 34-44, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536308
4.
Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study.
BMC Cancer
; 20(1): 169, 2020 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32126972
5.
Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients.
Eur J Haematol
; 102(1): 70-78, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30230047
6.
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
Eur J Haematol
; 97(3): 303-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26710662
7.
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world study.
EJHaem
; 5(2): 316-324, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38633122
8.
Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma-a randomized controlled feasibility study.
Pilot Feasibility Stud
; 5: 130, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31741745
9.
A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma.
Exp Hematol Oncol
; 7: 18, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30123673
10.
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Cancer Med
; 6(7): 1807-1816, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28639741
11.
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
PLoS One
; 12(12): e0188988, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29216227
12.
The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials.
Leukemia
; 33(2): 546-549, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267010
13.
Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014.
Leukemia
; 32(9): 2054-2057, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29500392
14.
[Indications for radioimmunotherapy for patients with non-Hodgkin's lymphoma]. / Indikationer for radioimmunterapi til patienter med non-Hodgkins lymfom.
Ugeskr Laeger
; 173(20): 1417-21, 2011 May 16.
Artículo
en Da
| MEDLINE | ID: mdl-21586245
15.
[Burkitt lymphoma is a highly malign tumour with a doubling time of twenty-four hours]. / Burkitts lymfom er en højmalign tumor med en fordoblingstid på et døgn.
Ugeskr Laeger
; 173(43): 2714-8, 2011 Oct 24.
Artículo
en Da
| MEDLINE | ID: mdl-22027227
Resultados
1 -
15
de 15
1
Próxima >
>>